Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

Finasteride use is linked to a higher risk of obstructive sleep apnea.

Oral baricitinib is effective and safe for treating alopecia areata.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

Most dermatologists in Western Rajasthan prefer the anti-depressant Doxepin for elderly skin conditions and often refer patients to a psychiatrist.

JAK inhibitors are effective and generally safe for treating alopecia areata, but monitoring for side effects is important.

WNMFDDA effectively predicts drug-disease associations.

Minoxidil reacts to nitrosation 7 times more than phenol, mainly due to its -NH₂ groups, leading to the creation of N-nitrosominoxidil.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Non-daily Dutasteride is more cost-effective and has lower cancer incidence than daily treatment.

5α-reductase inhibitors do not improve survival in oesophageal and gastric cancer patients.

MK-5108 is safe and shows potential against tumors, especially alone.

Plaquenil can cause a severe skin reaction called AGEP, requiring prompt diagnosis and treatment.

Dupilumab effectively reduces symptoms of prurigo nodularis and is safe for long-term use.

Low-dose oral minoxidil is safe for hair loss, with no link between side effects and patient demographics.

Androgens may increase arrhythmias in Brugada Syndrome, while Finasteride could reduce them.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Alopecia areata is rare in organ transplant patients and may be linked to the drug tacrolimus.

A woman with leprosy improved after stopping dapsone and getting treatment for a severe skin reaction and nail changes.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Spironolactone can safely lower blood pressure in patients on other blood pressure medications, but may slightly increase the risk of low blood pressure.

YH0618 helped reduce skin and nail problems and fatigue in chemotherapy patients.

Baricitinib significantly improves nail and hair symptoms in severe alopecia areata.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

Fast-dissolving nifedipine tablets were successfully developed for better oral delivery.

High amphiregulin in the skin is a bad sign for acute graft-versus-host disease.

Low-dose oral minoxidil may cause side effects like hypertrichosis and is not suitable for everyone.